Radiotherapy Market Is Projected to Gain $11.9 Billion by 2031, Growing at a 6.3% CAGR: Allied Market Research
Allied Market Research
Allied Market Research

The global radiotherapy market is experiencing growth because of various factors, such as the rise in cancer, advancements in radiotherapy machinery, and the rise in the geriatric population. Based on region, the market across Asia-Pacific would portray the highest CAGR during the forecast period.

Wilmington, Delaware, Nov. 13, 2023 (GLOBE NEWSWIRE) -- According to the recent report published by Allied Market Research, the global radiotherapy market size is projected to gain $11.9 billion by 2031, having endorsed a value of $6.5 billion in 2021, exhibiting a considerable CAGR of 6.3% from 2021 to 2030. This market report offers a comprehensive overview of the most prominent investment pockets, the top market segments, the current market dynamics, the market size and estimates, the competitive landscape, and regional insights. It is an essential resource for investors and shareholders, as well as for leading market players seeking to plan and strengthen their competitive edge. 

Request Sample of the Report on Radiotherapy Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/2367

Report Coverage and Details:

Report Coverage

Details

Forecast Period

2021-2030

Base Year

2021

Market Size in 2021

$6.5 Billion

Market Size in 2030

$11.9 Billion

CAGR

6.3%

No. of Pages in Report

210

Segments Covered

Type, End User, and Region

Drivers

Rise in cancer

 

Advancements in radiotherapy machinery

 

The rise in the geriatric population

Restraints

High cost of treatment

 

The potential side effects and risks associated with the use of certain medications

Opportunities

Technological advancements and innovation

 

The increase in the prevalence of cancer in developing countries

Recent Developments in the Radiotherapy Market

  • In January 2022, IBA (Ion Beam Applications) launched a new low energy and compact size cyclotron, the Cyclone KEY. This new machine is expected to enable small- and medium-sized hospitals to produce their own radiopharmaceutical products in-house, whilst providing more widespread global access to diagnostic solutions in oncology, neurology, and cardiology.

  • In October 2021, Accuray Incorporated launched its new VOLO Ultra for the radixact system, at ASTRO 2021. VOLO Ultra is a new way of planning with the Accuray precision treatment planning system, which enables users to plan with ease, optimize with quality, and deliver treatments with efficiency.

  • In September 2020, Elekta launched its Elekta Harmony, a linear accelerator (linac), which is used for cancer treatment. This system is designed to meet healthcare centers’ need for a productive, precise, and versatile radiotherapy treatment system. Harmony perfectly balances productivity, versatility, and precision without compromise, making it a solution for both, mature and developing markets.

  • In June 2021, IBA (Ion Beam Applications) launched its new high energy and high-capacity cyclotron, the Cyclone IKON, which offers the largest energy spectrum for PET and SPECT isotopes from 13 MeV to 30 MeV.